Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan
· Delayed Price · Currency is TWD 71.90
-0.60 (-0.83%)
Apr 29, 2026, 1:30 PM CST
Excelsior Medical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,336 | 14,000 | 14,052 | 13,757 | 10,019 | 8,130 | Upgrade
|
| Market Cap Growth | -13.92% | -0.37% | 2.15% | 37.31% | 23.23% | 2.67% | Upgrade
|
| Enterprise Value | 13,487 | 15,358 | 11,054 | 14,022 | 9,593 | 6,612 | Upgrade
|
| Last Close Price | 71.90 | 75.85 | 72.85 | 68.46 | 48.07 | 36.93 | Upgrade
|
| PE Ratio | 15.36 | 17.37 | 18.22 | 18.43 | 15.01 | 13.39 | Upgrade
|
| Forward PE | - | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | Upgrade
|
| PS Ratio | 1.40 | 1.59 | 1.65 | 1.67 | 1.39 | 1.24 | Upgrade
|
| PB Ratio | 1.05 | 1.19 | 1.24 | 1.26 | 0.97 | 0.83 | Upgrade
|
| P/TBV Ratio | 1.35 | 1.53 | 1.58 | 1.61 | 1.23 | 1.06 | Upgrade
|
| P/FCF Ratio | - | - | 5.96 | - | 21.52 | 10.42 | Upgrade
|
| P/OCF Ratio | - | - | 5.69 | 128.44 | 15.73 | 8.60 | Upgrade
|
| EV/Sales Ratio | 1.53 | 1.75 | 1.30 | 1.70 | 1.34 | 1.01 | Upgrade
|
| EV/EBITDA Ratio | 9.38 | 16.62 | 11.68 | 16.19 | 12.94 | 9.21 | Upgrade
|
| EV/EBIT Ratio | 11.95 | 21.11 | 14.67 | 19.95 | 15.81 | 11.11 | Upgrade
|
| EV/FCF Ratio | -9.36 | - | 4.69 | - | 20.61 | 8.47 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.18 | 0.13 | 0.13 | 0.08 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 2.08 | 2.08 | 1.36 | 1.49 | 0.98 | 0.96 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.61 | - | 1.74 | 0.98 | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.12 | -0.32 | -0.18 | -0.23 | -0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.49 | -1.49 | -3.83 | -2.27 | -3.26 | -4.19 | Upgrade
|
| Net Debt / FCF Ratio | 0.96 | 0.96 | -1.54 | 101.91 | -5.20 | -3.86 | Upgrade
|
| Asset Turnover | 0.45 | 0.45 | 0.44 | 0.48 | 0.46 | 0.45 | Upgrade
|
| Inventory Turnover | 4.97 | 4.97 | 5.12 | 5.45 | 5.48 | 5.90 | Upgrade
|
| Quick Ratio | 1.41 | 1.41 | 1.29 | 1.38 | 1.44 | 1.66 | Upgrade
|
| Current Ratio | 1.67 | 1.67 | 1.47 | 1.60 | 1.66 | 1.88 | Upgrade
|
| Return on Equity (ROE) | 8.37% | 8.37% | 8.72% | 8.70% | 7.84% | 7.47% | Upgrade
|
| Return on Assets (ROA) | 2.31% | 2.31% | 2.45% | 2.54% | 2.40% | 2.56% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.78% | 6.58% | 7.47% | 6.74% | 6.77% | 7.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.70% | 5.70% | 6.20% | 6.20% | 5.70% | 5.90% | Upgrade
|
| Earnings Yield | 6.53% | 5.76% | 5.49% | 5.43% | 6.66% | 7.47% | Upgrade
|
| FCF Yield | -11.68% | -10.30% | 16.77% | -0.14% | 4.65% | 9.60% | Upgrade
|
| Dividend Yield | 5.93% | 5.67% | 5.22% | 5.04% | 6.56% | 7.80% | Upgrade
|
| Payout Ratio | 77.05% | 77.05% | 76.67% | 72.45% | 74.02% | 81.37% | Upgrade
|
| Buyback Yield / Dilution | -0.04% | -0.04% | 0.01% | 0.09% | 0.05% | -0.34% | Upgrade
|
| Total Shareholder Return | 5.90% | 5.63% | 5.23% | 5.12% | 6.61% | 7.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.